Quality Drive + People Powered

Built for sponsors seeking speed, reliability, and scale, CorePharma delivers an integrated CDMO model that brings development and commercial manufacturing together under one roof. With deep expertise across preformulation, formulation development, analytical services, cGMP manufacturing, and packaging, programs move efficiently from early characterization through market-ready dosage forms.

Operating from a U.S.-based campus with multiple FDA- and DEA-approved facilities, the organization supports a wide range of solid oral technologies, including immediate- and modified-release tablets and capsules, ODTs, multiparticulates, and amorphous dispersions. Analytical rigor underpins every stage, with validated methods, ICH stability programs, and scalable manufacturing capabilities reaching commercial volumes.

A strong compliance track record, including zero FDA 483 observations across a decade of inspections, reinforces a quality-first culture. Combined with solvent-to-aqueous innovation, flexible batch sizing, and client-centric project management, the model is designed to reduce risk and accelerate timelines. For teams looking to simplify tech transfer, streamline supply chains, and move confidently from lab to launch, this overview highlights a partner built for execution. Explore the full one-pager to see how an end-to-end approach can support your next program.